You’re reading the web version of Health Care Inc., STAT’s weekly newsletter following the flow of money in medicine. Sign up ...

STAT gathered reactions from leaders across biotech and pharma about what the new Trump era could mean for them.

AbbVie said Monday that its experimental treatment for schizophrenia failed to significantly help patients in two trials, a ...

Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, ...

WASHINGTON — Newly empowered Republican leadership in the White House and in Congress will likely bring some good news and ...

With the reelection of Donald Trump, we could be looking at further erosion of any semblance of oversight of supplements on ...

New studies to be presented at the American Heart Association meeting focus on disparities in Wegovy prescriptions and ...

This story first appeared in The Readout newsletter. Sign up for The Readout and receive STAT’s award-winning biotech news ...

Today's health news includes one woman's experience with sickle cell disease, what RFK and Trump can actually do on vaccines, ...

You're reading Part 5 of Coercive Care, a yearlong examination of the denial of reproductive autonomy for people with sickle ...

When patients and their families leave the emergency room, they’re usually clutching a sheaf of papers: Called discharge notes, they contain important instructions about how to care for themselves and ...

RFK Jr. has said Trump promised him “control of the public health agencies,” including the National Institutes of Health and ...